---
title: "CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 241.6 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251805966.md"
datetime: "2025-08-06T10:08:57.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251805966.md)
  - [en](https://longbridge.com/en/news/251805966.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251805966.md)
generator: "portal-rs"
---

# CLARITEV CORPORATION C/WTS 08/10/2025(TO PUR COM) | 8-K: FY2025 Q2 Revenue: USD 241.6 M

Revenue: As of FY2025 Q2, the actual value is USD 241.6 M.

EPS: As of FY2025 Q2, the actual value is USD -3.81.

EBIT: As of FY2025 Q2, the actual value is USD 128.29 M.

### Segment Revenue

-   Q2 2025 Revenues: $241.6 million, an increase of 3.5% compared to $233.5 million in Q2 2024.

### Operational Metrics

-   Net Loss: $62.6 million for Q2 2025, compared to $576.7 million for Q2 2024.
-   Adjusted EBITDA: $154.0 million for Q2 2025, compared to $146.7 million for Q2 2024.
-   Operating Income: $16.6 million for Q2 2025, compared to an operating loss of $523.9 million for Q2 2024.

### Cash Flow

-   Net Cash Provided by Operating Activities: $61.2 million for Q2 2025, compared to $18.5 million for Q2 2024.
-   Free Cash Flow: $36.6 million for Q2 2025, compared to - $7.0 million for Q2 2024.

### Unique Metrics

-   Claim Charges Processed: Approximately $43.8 billion in Q2 2025, identifying potential medical cost savings of approximately $6.3 billion.

### Outlook / Guidance

Claritev Corporation’s forward-looking statements include expectations regarding the successful implementation of its transformation plan, execution of its international expansion plan, and its 2025 outlook and guidance. The company acknowledges risks and uncertainties that may cause actual results to differ materially from those projected, including client loss, competition, and regulatory changes. Revenue guidance has been updated to flat to +2% from FY 2024, with free cash flow guidance updated to a range of - $20 million to $20 million for the year, and capital expenditures guidance updated to $170 million to $180 million for the year.

### Related Stocks

- [MPLNW.US](https://longbridge.com/en/quote/MPLNW.US.md)

## Related News & Research

- [Why is your gold waiting on a speech?](https://longbridge.com/en/news/296733808.md)
- [Michael Burry Says He 'Flipped' His Alibaba Stock into JD and Won't Be Flipping Back — Hong Kong-Listed Stock Falls Nearly 10% on $10B Raise](https://longbridge.com/en/news/296735167.md)
- [Balanced Risk/Reward Keeps Workday at Hold as Brent Thill Raises Price Target from $205 to $225 on Potential Silver Lake Takeout Upside](https://longbridge.com/en/news/296711228.md)
- [Micron Sees 'No End' to AI Memory Supply Crunch: CEO Sanjay Mehrotra Says 'Nothing Ever Goes in a Straight Line'](https://longbridge.com/en/news/296743524.md)
- [Turtle Creek Wealth Advisors LLC Acquires 2,496 Shares of Meta Platforms, Inc. $META](https://longbridge.com/en/news/296760939.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**